Reducing Mental Health Disparities Among Latinxs With a Telenovela Intervention

July 22, 2024 updated by: University of Nevada, Reno
The primary aim of our study is to determine the effectiveness of an transdiagnostic telenovela video intervention in reducing anxiety and depressive symptoms using a pre/post-test design with Spanish-speaking Latinxs.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Telenovela video interventions are a low-resource, low-cost methodology developed to diminish the treatment-provider gap (Heilemann et al., 2017). Research shows that telenovela interventions represent an acceptable (Heilemann et al., 2018) and potent (Heilemann et al., 2017) intervention option for disseminating information to the Latinx population. Prior research utilizing transmedia telenovela interventions that include a telenovela component have demonstrated some effectiveness at reducing symptoms of anxiety and depression among Latinxs (Heilemann et al., 2017; Kajiyama et al., 2018) as have fotonovelas (Sanchez et al., 2019). To date researchers have not investigated how the telenovela approach combined with a transdiagnostic treatment paradigm might help reduce behavioral health disparities among Spanish-speaking Latinxs given that such an intervention would be easily disseminable and target the two most common disorders observed among this population. The primary aim of this study is to determine the effectiveness of an transdiagnostic telenovela video intervention in reducing anxiety and depressive symptoms using a pre/post-test design with Spanish-speaking Latinxs.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Nevada
      • Reno, Nevada, United States, 89557
        • Recruiting
        • La Clinica @ the UNR Psychological Services Center
        • Contact:
        • Contact:
          • Phone Number: 7757505726

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 18 years or older
  2. Identify as Latinx
  3. Prefer behavioral health services in Spanish
  4. Meet the DSM criteria for any mild to moderate anxiety disorder
  5. Ownership of a smartphone

Exclusion Criteria:

  1. Suicidality
  2. Psychosis
  3. Bipolar disorder
  4. Severe anxiety disorders
  5. Severe depressive disorders
  6. Homicidality

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telenovela Arm
The UP telenovela (which is the experimental treatment arm) constitutes of nine videos depicting the main character, Esperanza, who is struggling with anxiety and depression, undergoing therapy involving the UP, and completing worksheets relating to the weekly therapy sessions.
Behavioral: Transdiagnostic Telenovela Intervention
The intervention constitutes nine videos depicting the main character, Esperanza, who is struggling with anxiety and depression, undergoing therapy involving the a trandiagnostic treatment, and completing worksheets relating to the weekly therapy sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Generalized Anxiety Disorder-7
Time Frame: Two weeks
Assesses the presence of anxiety symptoms in the past two weeks. Lower scores mean better outcomes. Scores range from 0 to 35.
Two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Nevada, Reno

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Estimated)

December 30, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

November 22, 2023

First Submitted That Met QC Criteria

November 30, 2023

First Posted (Actual)

December 11, 2023

Study Record Updates

Last Update Posted (Actual)

July 24, 2024

Last Update Submitted That Met QC Criteria

July 22, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1864886-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe